HELXvsGNOMETF Comparison
Franklin Genomic Advancements ETF (HELX) and Global X Genomics & Biotechnology ETF - USD (GNOM) belong to the same industry segment: BioTech & Genomics. HELX's top 3 sector exposures are Health Care, Materials and Information Technology. In contrast, GNOM's top sector exposures are Health Care, Both HELX and GNOM have the same Total Expense Ratio (TER) of 0.5%. HELX is down -7.69% year-to-date (YTD) with +$2M in YTD flows. GNOM performs better with 0.74% YTD performance, and -$602K in YTD flows. Run a side-by-side ETF comparison of HELX and GNOM below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
HELX vs GNOM performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | HELX GNOM | +5.41%+7.67% | -10.90%-7.03% | -7.69%+0.74% | +23.56%+41.51% | +9.47%-6.56% | -30.03%-50.60% |
| Flows | HELX GNOM | --$829K | -+$1M | +$2M-$602K | +$8M-$14M | +$9M-$120M | +$14M+$1M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | HELX GNOM | +24.83%+28.47% | +20.80%+27.16% | +20.28%+28.79% | +23.68%+33.22% |
| Max drawdown | HELX GNOM | -16.86%-16.08% | -17.89%-18.16% | -29.16%-46.50% | -58.50%-72.17% |
| Max drawdown duration | HELX GNOM | 88d88d | 145d92d | 458d1075d | 1690d1758d |
HELX | GNOM | |
Last sale 4/27/2026 at 1:30 PM | $33.63 | $45.55 |
| Previous close 04/24/2026 | $33.53 | $45.97 |
| Consolidated volume 04/24/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
HELX | GNOM | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
HELX | GNOM | |
|---|---|---|
| Last price | $33.63 | $45.55 |
| 1D performance | +0.31% | -0.92% |
| AuM | $21.77 M | $51.60 M |
| E/R | 0.5% | 0.5% |
HELX | GNOM | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | Franklin Templeton | Global X |
| Benchmark | - | Solactive Genomics Index |
| N° of holdings | 51 | 45 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | February 25, 2020 | April 5, 2019 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
